Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Long-Term Debt
$1.35M
Quarterly · Period ending: · USD
LCTX Long-Term Debt
Latest reported$1.35Mperiod ending
Latest reported$1.35Mperiod ending
LCTX Quarterly Long-Term Debt ($0.00 → $1.35M)
Quarterly long-term debt
High-resolution chart · PNG
LCTX long-term debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Long-Term Debt (USD) |
|---|---|
| 1,348,000 | |
| 1,529,000 | |
| 1,566,000 | |
| 1,555,000 | |
| 1,106,000 | |
| 1,064,000 | |
| 1,362,000 | |
| 1,613,000 | |
| 1,836,000 | |
| 2,153,000 | |
| 2,070,000 | |
| 2,144,000 | |
| 2,417,000 | |
| 2,675,000 | |
| 2,944,000 | |
| 2,232,000 | |
| 1,478,000 | |
| 1,807,000 | |
| 1,971,000 | |
| 1,899,000 | |
| 2,094,000 | |
| 2,243,000 | |
| 2,540,000 | |
| 1,829,000 | |
| 3,338,000 | |
| 3,593,000 | |
| 3,945,000 | |
| 4,174,000 | |
| 3,918,000 | |
| 4,119,000 | |
| 1,958,000 | |
| 110,000 | |
| 116,000 | |
| 122,000 | |
| 1,169,000 | |
| 1,301,000 | |
| 1,396,000 | |
| 2,516,000 | |
| 2,848,000 | |
| 2,564,000 | |
| 2,382,000 | |
| 6,054,000 | |
| 4,970,000 | |
| 4,357,000 | |
| 3,334,000 | |
| 578,277 | |
| 409,000 | |
| 44,963 | |
| 57,500 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 52,641 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 2,249,835 | |
| 2,308,764 | |
| 2,168,804 | |
| 2,042,319 | |
| 1,927,978 | |
| 1,824,601 | |
| 1,731,122 | |
| 0 |